Johnny Y. Nagasawa - Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Correction: the Selective Estrogen Receptor Downregulator GDC-0810 is Efficacious in Diverse Models of ER+ Breast Cancer

eLife（2019）

Cited117Views0WOSBibtex

117

Erratum: Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer (eLife (2016) 5 PII: e44851)

eLife (2019)

Cited1Views0Bibtex

SUSTAINED FXR ACTIVATION OUTPERFORMS THRB ACTIVATION IN DIET-AND CHEMICAL-INDUCED MURINE MODELS OF NASH WITH ADVANCED FIBROSIS

Brandee Wagner,Steve Govek,Johnny Nagasawa,Karensa Douglas,Angelica Milik,Kyoung-Jin Lee,Alvaro Ortiz,Douglas Zook,Jing Qian,Nhin Lu,Eric Bischoff,Kirstine Sloth Tolbol,Sanne Veidal,Michael Feigh,Ken Song,Nicholas Smith

HEPATOLOGY（2019）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn